Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3770878015 | Cabazitaxel only product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3770879011 | Product containing only cabazitaxel in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Cabazitaxel only product in parenteral dose form | Is a | Product containing only cabazitaxel (medicinal product) | true | Inferred relationship | Some | ||
Cabazitaxel only product in parenteral dose form | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
Cabazitaxel only product in parenteral dose form | Is a | Cabazitaxel-containing product in parenteral dose form | true | Inferred relationship | Some | ||
Cabazitaxel only product in parenteral dose form | Count of base of active ingredient | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
Cabazitaxel only product in parenteral dose form | Has active ingredient | Cabazitaxel (substance) | true | Inferred relationship | Some | 1 | |
Cabazitaxel only product in parenteral dose form | Plays role | Antineoplastic therapeutic role | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Cabazitaxel 40 mg/mL solution for injection | Is a | True | Cabazitaxel only product in parenteral dose form | Inferred relationship | Some |
This concept is not in any reference sets